Objectives Solubility parameters have been used for decades in various scientific fields including pharmaceutics. It is, however, still a field of active research both on a conceptual and experimental level. This work addresses the need to review solubility parameter applications in pharmaceutics of poorly water-soluble drugs. Key findings An overview of the different experimental and calculation methods to determine solubility parameters is provided, which covers from classical to modern approaches. In the pharmaceutical field, solubility parameters are primarily used to guide organic solvent selection, cocrystals and salt screening, lipid-based delivery, solid dispersions and nano-or microparticulate drug delivery systems. Solubility parameters have been applied for a quantitative assessment of mixtures, or they are simply used to rank excipients for a given drug. Summary In particular, partial solubility parameters hold great promise for aiding the development of poorly soluble drug delivery systems. This is particularly true in early-stage development, where compound availability and resources are limited. The experimental determination of solubility parameters has its merits despite being rather labour-intensive because further data can be used to continuously improve in silico predictions. Such improvements will ensure that solubility parameters will also in future guide scientists in finding suitable drug formulations.
Introduction
Solubility parameters have received much attention and numerous applications have been reported in diverse scientific fields. [1] Pharmaceutics has been a prime discipline for applying solubility parameters to formulation design. Previous studies have, for example, reported the use of solubility parameters to predict suitable solvents for solutes, select polymer blends, and to describe surface and adhesion phenomena. [1] It would be interesting to have an overview of such pharmaceutical applications with a particular emphasis on the development of poorly soluble drug formulations.
Development of new formulations requires the use of different tools to predict and analyse the physiochemical properties and interactions of dosage form components. [2, 3] For prediction of material properties and their interactions, for example, solubility parameters are routinely used with high levels of success. [2] Historically, this strategy has been employed in drug development for the selection of solvents for coating. Since then, further applications, as well as more robust thermodynamic methods for solubility parameter calculations, have also been reported. Specifically, such thermodynamic methods can be used for study and prediction of the physical and chemical properties of compounds together with their effects on mixtures and dosage forms. [2] The definition of solubility parameter was first coined by Hildebrand and Scott in 1950 . [1] An important theoretical development was then proposed later in 1967 with introduction of the so-called Hansen solubility parameter (HSP). [1] This concept divides the total solubility parameter (d t ) into three different contributions: polar, nonpolar and hydrogen bonding, and it is therefore more versatile than the original one-dimensional solubility parameter defined by Hildebrand, which does not account for these specific contributions. [2] Solubility parameters can be derived experimentally from heat of vaporisation, internal pressures, surface tensions and other material characteristics as outlined by Hildebrand and Scott. [4] Since then, a number of researchers have reported new methods to more accurately predict solubility parameter values, considering, for example, purely acidic or basis compounds [5] for a specific process technique. [6] More recent predictions of solubility parameters rely on molecular dynamics simulations or on the conductor-like screening model (COSMO), and these computational methods have been compared by Diaz et al. [7] Important in this context is the research of Panayiotou and coworkers who contributed to the theoretical concept of solubility parameter and proposed a modern quantitative structure-property relationship. [8] Furthermore the recent article by Louwerse et al. broadly summarised limitations of the solubility parameter concept and proposed theoretical improvements. [9] Previously, various authors [2, 10, 11] have shown the practical importance of solubility parameters, but a general overview of their applications in the pharmaceutical field is missing. This article addresses the particular need to review the use of solubility parameters in pharmaceutics with respect to formulation of poorly soluble drugs. The latter oral delivery systems are central to the PEARRL research consortium that is deals with the design of such formulations and new tools for their biopharmaceutical assessment.
Theory and experimental aspects of the solubility parameter concept Introduction to the solubility parameter concept
The principle of 'like dissolves like' is a well-known term within chemical and pharmaceutical sciences, which can be more generally described as 'like seeks like'. The usefulness of such approaches depends of course on the ability to assign a numerical value to molecular similarity or dissimilarity. Such a quantitative number is provided by the solubility parameter, which is a rather simple but very powerful approach.
For a better understanding of the solubility parameter concept, it is helpful to discuss its historical origins that are linked to the theory of nonideal solutions. For such solutions, the activity of a solute, a 2, is the product of the concentration X 2 (mole fraction) and the activity coefficient, c 2 (Equation 1):
It is a central task of thermodynamic theories to predict c 2 and a classical approach is that by Scatchard [12] and by Hildebrand and Wood: [13] ln c 2 ð Þ ¼ w 22 þ w 11 À 2w 12 ð Þ V 2 u 2 1
RT ð2Þ
where V 2 is the volume of the solute and φ 1 is the volume fraction of the solvent and R and T are the gas constant and temperature, respectively (Equation 2). The term w 11 denotes the energy needed to remove solute molecules from the bulk, while w 22 equals to the idealised removal of solvent molecules to generate a cavity in the solvent for the molecule to dissolve. Such an idealised transfer of the molecule would lead to gained insertion energy in the solvent or release of solvation energy of À2w 12 . It was an important idea to approximate the interaction term w 12 by the square root of the product of w 11 and w 22 
RT ð3Þ
The advantage of having only pure component properties of the solvent and solute in Equation 3 is that they can be listed for the different chemicals without the need to additionally determine a specific interaction parameter like w 12 . Hildebrand and Scott [4] coined the notion of the solubility parameter d x that is here given for the solute as follows (Equation 4):
The solubility parameter is the square root of energy per volume, and it is often named as square root of cohesive energy density. Units can also be expressed in MPa 0.5 and hence can also be viewed as an internal pressure.
Equations (3) and (4) show that in the absence of differences in the solubility parameters, the activity coefficient c 2 becomes unity so that ideal solubility is reached and activity and concentration are equal. Regular solution theory does not consider more complex nonideal solutions that may lead to an activity coefficient of smaller than unity. Even though regular solution theory is limited in scope, it marked the birth of the solubility parameter concept that is more broadly applicable.
The solubility parameter, for example, can be applied to any mixing process. According to Hildebrand and Scott, the enthalpy of a mixing process is proportional to the square difference in solubility parameters for the mixture components, d 1 and d 2 (Equation 5) [4] :
where φ 1 and φ 2 are the volume fractions of the mixing components that can be, for example, a drug and polymer.
Apart from mixing enthalpy, a solubility parameter can be linked to any thermal property or to any other molecular interaction parameter. A latter example is the well-known Flory chi parameter v 12 that can be expressed in terms of Equation 6 for mixtures that involve a polymer [1, 14] :
where b is an entropy correction term and V is the molar volume of a solvent or drug in mixture with a polymer. It seems that b may not be required for essentially nonpolar systems, but in other cases, such an empirical correction of b may be needed to avoid under prediction of v 12 . [1, 14] These examples show that particular care is needed when the solubility parameter is used for quantitative conversion to other physicochemical properties or parameters. The solubility parameter approach is comparatively simple but the art lies in correct application for each given system. The total solubility parameter is, for example, primarily useful to describe apolar components, whereas Hansen introduced the more versatile concept of partial solubility parameters. [1, 15] As previously mentioned, the basic idea in this approach is to split the total cohesion energy (E tot ) into different parts that originate from separate molecular interactions. The dispersive energy (E d ) stems from atomic nonpolar forces, i.e. dispersive Van der Waals interactions, whereas forces between molecules of permanent dipoles constitute a polar energy contribution (E p ). Due to the specific nature of hydrogen bonding, this energy contribution is considered separately (E h ). These partial cohesion energies E d , E p and E h are divided by molar volume to result in the corresponding total and partial solubility parameters according to Equations (7) and (8) [1] :
Equation 8 shows that a three dimensional (3-D) version of the solubility parameter is obtained by consideration of the different partial contributions to cohesive energy density. Figure 1 depicts a series of solvents in this space of dispersive, polar and hydrogen bonding contribution to the HSP. The invention of partial solubility parameters has certainly advanced the original cohesive energy density approach and opened the field to diverse potential applications wherever molecular interactions of the type 'like seeks like' play a critical role. We will in the following part first describe the different ways to obtain total or partial solubility parameters and will then discuss the different applications in the pharmaceutical field. Finally, gaps and current trends will be discussed.
Experimental and in silico determination of solubility parameters
Introduction to solubility parameter determination Solubility parameters can be evaluated directly by vaporisation of solvents (or sublimation of solids) as described in the original definition. This, however, is only feasible for materials that can be either vaporised or sublimated (in case of solids), which is often not possible. Many pharmaceutically relevant materials, such as coating polymers, polymers for amorphous solid dispersions, drug compounds or surfactants, require other methods. Therefore, indirect methods have been widely used in the literature for determination of solubility parameters, which are based upon relationships between diverse physicochemical properties and cohesion energy. Solubility parameters can be deduced from measurements of other substance properties than vaporisation. Some of the different methods to obtain a solubility parameter are schematically depicted in Figure 2 , and for further reference, see the comprehensive review on this topic by Barton. [16] Values for solubility parameters determined using these various methods may vary based upon method set-up and/or material. This section describes the methods that have or could be used to characterise pharmaceutical compounds.
Classical determination of solubility parameter
Classical approach via latent heat of evaporation. As mentioned earlier, the (total) solubility parameter, was introduced by Hildebrand and Scott, and was defined as the root of the cohesive energy density (CED). The cohesive energy density was in turn defined as the energy needed to break all attractive interactions in one mole of a solvent divided by the molar volume according to Equation 9 :
Equation 10 can be expressed in terms of latent heat of vaporisation DH v (in case of solvents) the universal gas constant R and the absolute temperature T. DH v can be obtained from calorimetric or vapour-pressure data to finally determine d t .
Hansen expanded the total solubility parameter into three components, d d , d p and d h , as discussed for Equation 8 . This means for nonpolar molecules that d p and d h are zero, and hence, d t equals d d . For polar molecules, the situation is more difficult and calculation methods were developed to assess the partial solubility parameters based on accessible physical properties.
Calculation of the nonpolar dispersion solubility parameter. The energy of evaporation can be divided into a polar and nonpolar part using the homomorph approach. [17] [18] [19] The homomorph of a polar molecule is a nonpolar molecule with nearly the same size and shape as that of the polar molecule of interest. The dispersion energy part of evaporation of a polar molecule is therefore approached by the energy of evaporation of the homomorph at the same reduced temperature, T r . The reduced temperature T r is defined as follows:
Equation 11 includes the absolute temperature T and the critical temperature T c , which can be estimated based upon the Lydersen group contributions. [1] Corrections to this approach are required for molecules containing atoms which are significantly greater than carbon, e.g. chlorine, bromine, sulfur, but not for oxygen and nitrogen. [1] For instance, when the evaporation energy of the nonpolar carbon tetrachloride is compared with the nonpolar homomorph 2,2 dimethyl propane, a difference of 1580 cal/mol (6610 J/mol) is found. This difference is divided by four to obtain a correction factor for a chlorine atom in a molecule. [20] Dividing by the molar volume and then taking the square root (see Equation 9) gives the dispersion solubility parameter. [1] Calculation of the polar solubility parameter. The polar parameter of a polar molecule was originally calculated by Hansen and Skaarup [20] using the B€ ottcher equation and expressed in cal/cm³ (Equation 12):
where l is the dipole moment, in Debye, V m the molar volume in cm³/mole, n D the refractive index using the sodium D line and e the dielectric constant. Later a more simplified equation was used by Hansen and Beerbower [21] according to Equation 13 in (MPa)
Calculation of the hydrogen bond solubility parameter. Hansen and Skaarup [20] used data from infrared spectroscopy to assign an energy of evaporation of 5000 cal/ mol for the OH-O hydrogen bond; hence, for a solvent containing hydroxyl groups, the hydrogen solubility parameter can be calculated utilising Equation 14 :
where N is the number of alcohol groups in the solvent molecule. More often, d h is calculated by subtracting the dispersion and polar contributions from the total solubility parameter according to Equation 15 [1, 22] :
As hydrogen bonding has a profound effect on solubility, attempts have been undertaken to further expand the hydrogen bond solubility parameter. A hydrogen bond comprises a hydrogen bond donor and a hydrogen bond acceptor, and molecules can therefore be classified as [16] (1) proton donor, e.g. trichloromethane; (2) proton acceptor, e.g. ketones, aldehydes, esters, ethers, tertiary amines, aromatic hydrocarbons, alkenes; (3) proton donor/acceptor, e.g. alcohols, carboxylic acids, water, primary and secondary amines; and (4) proton nondonor/nonacceptor, e.g. alkanes, carbon disulfide and tetrachloromethane. From a qualitative point of view, miscibility can be predicted if hydrogen bonds are formed upon mixing, while demixing occurs when hydrogen bonds are destroyed (e.g. water mixed with alkanes).
An extension of the hydrogen bond solubility parameter to account for hydrogen bond donor and acceptor properties has been suggested by Small [23] and others (Sorenson et al. [24] ), using Equation 16 :
where d a is the acidic solubility parameter (the donor proton of the hydrogen bond, which is the electron acceptor in the Lewis acid framework) and d b is the basic solubility parameter (Lewis base, electron donor). Beerbower and Martin [21] developed the concept to estimate the solubility of naphthalene, benzoic acid, p-hydroxybenzoic acid and methyl p-hydroxybenzoate in different solvents. [25] However, improvement in accurate miscibility prediction was limited (e.g. benzoic acid: 63% acceptable -i.e. less than 30% error vs observed -predictions using four parameters vs 60% acceptable predictions with the three Hansen solubility parameters).
Determination of partial solubility parameters using solvent solubility data Determination of solubility parameters for drug substances and polymers typically cannot be accomplished through the measurement of the energy of evaporation (because of their nonvolatility and due to the fact that evaporation frequently is accompanied by degradation) and therefore only indirect methods can be used. Solubility determination of a solid in a series of selected solvents, which cover the solubility design space in terms of d d , d p and d h , is a frequently used technique to achieve this goal. [1, [26] [27] [28] [29] [30] [31] [32] Typically, 10-40 solvents are used for the solubility measurements, which can be conducted as, e.g. a classical shake-flask approach where the thermodynamic solubility is determined or only kinetic solubility values are estimated by continuously adding small drug amounts to solvents with optical detection of residual drug. Generally, the solvents are selected such that the compound of interest has good solubility in at least half of the solvents screened. The solubility parameters can then be calculated with multiple regression analysis based on mole fractions solubilised in the various solvents [27, 28] or with more modern computer software that uses an iterative method for improving drug solubility parameter estimates in a Cartesian coordinate system (Figure 1 
The distances between the sample reference point to point representations are calculated for solvents. Then the iterative method adjusts the partial solubility parameters such that the distance between compatible and incompatible solvents are minimised and maximised, respectively. This iterative minimisation/maximisation process can then determine a more reliable solubility parameter as recently done by Howell and coworkers. [33] Drug substances as well as polymers can be used as samples. For example, HPMC and HPMCAS are frequently used polymers in stabilised amorphous solid dispersions and with the 'like dissolves like' approach the solubility parameter seems as a feasible way to provide a first guess on the active pharmaceutical ingredient (API) miscibility in these systems. An overview of experimentally determined HSP using the solvent method is provided in Table 1 . For HPMCAS, the values were consistent between three independent determinations (see references given in Table 1 ). For HPMC, a difference was noted for the polarity and hydrogen bonding parameters between Janssen and Archer. [34] This may be attributed both to (1) substantial difference in molecular weight, (2) the usage of a limited number of solvents, e.g. 10 and (3) the usage of water as solvent by Archer, [34] which is generally not recommended due to the complexity of the solvent. [1] Solubility parameters obtained via the solvent approach have also been reported for characterisation of drug molecules and solid excipients such as, preservatives. [25] [26] [27] 32, 35, 36] These studies use about 10-25 different solvents to obtain an accurate determination of the partial solubility parameters, which seems to be reasonable given the number of unknowns in the regression analysis. Verheyen and coworkers [27] investigated five chemically related molecules and reported that the method was sufficient enough to capture the differences between molecules. Barra et al. [26] reported a similar finding by investigating a number of free acids and their associated sodium salts and finally, as well as those results published by Kitak and coworkers [32] could find differences between two ibuprofen salts and the free acid. The method is therefore generally perceived as sufficiently precise to determine accurate partial solubility parameters by solubility screening in a number of organic solvents or mixtures of these.
Determination of partial solubility parameters using intrinsic viscosity measurements
The use of viscosity measurements is a frequently used technique to determine the solubility parameter for 18.8 9.4 11.8 [194] 29 solvents, calculation using HSPiP software [67] HPMC 2910 E5 18.7 9.8 11.6 [194] 29 solvents, calculation using HSPiP software [67] Methylcellulose A4M [194] polymers. [1, [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] In this approach, the intrinsic viscosity of the polymer of interest is determined in a number of solvents. [1, 37, 39] Intrinsic viscosity, [g], is given by:
Equation 17 can be expressed in terms of the solution viscosity (g s ) or the solvent viscosity (g 0 ) where c is the solution concentration. The conformation of a polymer in solution is dependent on its interactions with the solvent. In so-called good solvents with many interactions, the polymers can swell to some extent, which increases of solutions viscosity. By contrast, in solvents with limited interactions (i.e. a 'poor solvent') the polymer will reduce the contact area to the solvent by shrinking. An interesting approach is to normalise intrinsic viscosities for a polymer in a solvent that provides the highest viscosity value. These normalised data can be used to determine the HSP according to the Equations below 18-20 [39] :
where the subscript 2 indicates the polymer and 'i' the solvents. The intrinsic viscosity of the i-th solvent is described by the parameter [g] i . The solvents that are most compatible have the highest intrinsic viscosities and are closest to the geometric centre of a sphere in the Hansen space that encloses good solvents. [1] The separating distance from the centre of the sphere to a last still compatible solvent provides the interaction sphere radius R 0 and is defined according to Equation 21:
where d di , d pi and d hi are partial solubility parameters of the last still compatible solvent, whereas d dp , d pp and d hp denote the partial solubility parameters of the sample polymer. Analogues to Equation 21 , is possible to calculate the distance between the sample polymer and any solvent, which is called 'solubility parameter distance', R a . This distance parameter is of more general use and is not restricted to viscosimetry to determine solubility parameters. An alternative method to determine the partial solubility parameters via intrinsic viscosity was developed by Mieczkowski. [47, 48] In this method, the values of the volume fraction of a solvent (φ s ) were determined for three mixtures of solvents at which the maximum intrinsic viscosity was found. These fractions were then inserted into to Equation 22: [43] also employed viscosity to determine the partial solubility parameter of HPMC with 28-30% methoxy and 7-12% hydroxypropyl content and an approximate molecular weight of 86 kDa (equivalent to Dow E4M). The experimental results were fitted according to following regression model (Equation 23):
ð23Þ whereas the subscript 1 refers to solvent and the subscript 2 in the following Equations 24-26 to the polymer:
An extended regression model was used to allow the determination of the Lewis acid (d a ) and base (d b ) solubility parameters according to Equation 27 :
Solubility parameters of HPMC for dispersion, polarity and hydrogen bonding were reported to be 14, 16.8 and 31 MPa 1/2 , respectively. As can be seen in Table 1 , the data obtained by Bustamante [43] for d d and d p were in line with the values obtain by Archer [34] while there was a substantial difference for the d h solubility parameter. This difference may be attributed to the use of different Hansen solubility parameters for water. Bustamante for dispersion, polar and hydrogen bonding respectively. Additionally, Madsen and coworkers [44] employed viscosity to determine the solubility parameter for the pharmaceutical polymers, PLGA and polycaprolactone (PCL). The authors demonstrated that the solubility parameter could be correlated with protein release from the two polymer systems. This example underpins again, how broadly the solubility parameter approach can be applied.
Determination of partial solubility parameters of liquids using inverse gas chromatography
The HSP for pharmaceutical liquids are difficult to determine experimentally using 'solubility' methods. Additionally, many pharmaceutical substances including, for example, polymers, polysorbates, ethoxylated oils and vitamin E TPGS are complex mixtures without defined chemical structure and hence are difficult to approach theoretically. In such cases, the determination of the HSP by inverse gas chromatography, is a valuable option. Inverse gas chromatography has been applied to investigate the solubility parameters of polymers, [40, [49] [50] [51] [52] surfactants, [53, 54] , epoxidised soybean oil, [55] triglycerides [56] and liquid crystal systems. [57] [58] [59] For measurement of solids, it is recommended for the samples to contain some amorphous fraction, so that the probe gases can enter the bulk. Otherwise, only surface interactions could skew the results for estimated solubility parameters.
Using the inverse gas chromatography method, the material of interest is the stationary phase and is placed into a column. It is then characterised using diverse volatile probes (i.e. volatile solvents with known HSPs). The HSP of the material can then be calculated based on the retention data of the solvent probes. [54] First, the retention times of the solvent probes are converted to specific retention volumes (V g ). These are then used to calculate the Flory-Huggins interaction parameter between the solvent and the sample using the following equation (Equation 28) [60] [61] [62] :
where v 1 1;2 is the Flory-Huggins interaction parameter between the material of interest and the solvent probe, M 1 is the molecular mass, P 1 is the vapour pressure of the solvent probe at the measurement temperature calculated using the Antoine equation, V 1 is the molar volume of the probe, V 2 is the molar volume of the examined material, B 11 is the second virial coefficient of the solvent probe calculated according to Voelkel and Fall, [63] q 1 and q 2 are the densities of the solvent probe and material, respectively. The total solubility parameter is then calculated using Equation 29 [50, 53, 64, 65] :
where d 1 is the total solubility parameter of the consecutive test solutes and d 2 the total solubility parameter of the material of interest, v 1 S is the entropic part of the Flory-Huggins interaction constant and is usually estimated in the range 0.2-0.4 or 0.6. [52] By plotting the left hand side of the equation vs d 1 , a straight line is obtained of which the slope and intercept are used to calculate d 2 .
Voelkel and Janas [66] extended this original concept, introduced by Price and Shillcock [57] to obtain partial solubility parameters from the linear relationships for solvent groups (n-alkanes for d 2d , polar solvents for d 2p and hydrogen bonding solvents for d 2h , while S is indicated as the value for the slope) according to Equations 30-32:
Using this approach Adamska and Voelkel [52] determined the HSPs of di-n-butyladipat (Cetiol), caprylocaproyl macrogol-8 glycerides (Labrasol, Gattefosse) and polysorbate 80 (Tween 80) using inverse gas chromatography. Packing of columns with semi-solids and liquid compounds often require special preparation and here, the excipients were dissolved in a suitable solvent to coat on a solid support by slow solvent evaporation. By comparison, an alternative method with fewer assumptions has been used for some of the same excipients investigated by Adamska and Voelkel [54] as described in Table 2 . The method used has some parallels with the solubility approach described above. In this method the three partial parameters were iteratively and systematically changed to give the best fit between predicted and experimental values for the interaction parameter, v 1 1;2 , for all the solvent probes tested; hence, no solvent probe families were needed. The predicted interaction constant was calculated according to Equation 33 :
where C 1 and C 2 are constants and V m is the molar volume of the solvent probe. This approach is adopted in the software package 'Hansen Solubility Parameters in Practice', HSPiP. [67] This software is helpful as it provides tools for many processes such as determining HSP from solubility data and, estimating HSP from the chemical structure as well as databases, which include HSP values for many polymers and excipients. The values obtained for polysorbate 80 and caprylocaproyl macrogol-8 glycerides (Labrasol, Gattefosse) were somewhat different than the ones obtained by Adamska and Voelkel. [54] This is possibly due to the use of different sample preparation methods and column packing material, which influences the retention volume determination. However, it should be also noted that it may be problematic to determine a solubility parameter for surfactants and other amphiphilic substances (e.g. some copolymers) by the use of only a single set of partial solubility parameters. Superstructures such as liquid-crystalline phases are typically formed and probe gas molecules can interact with different microdomains, which is an issue of sample heterogeneity.
Klar and Urbanetz [40] investigated the solubility parameter for hypromellose acetate succinate (granular type M HPMCAS) by turbidimetric titration, inverse gas chromatography and seven different calculation methods. The total solubility parameter determined by turbidity was 24.7 AE 3.2 MPa 1/2 for moderately hydrogen bonded solvents and 24.4 AE 0.3 MPa 1/2 when determined by inverse gas chromatography. Furthermore, the partial HSPs that were determined by inverse gas chromatography and obtained data (17.69, 12.06 and 11.7 MPa 1/2 for dispersion, polar and hydrogen bonding respectively) showed good accordance with the value generated by the calculation methods, especially those calculated via the Hoy and Te Nijenhuis method, using experimentally determined molecular volumes, [40] as well as the Janssen and Dow values determined from solubility data, see Table 1 .
In summary, even though the practice and the theory to determine solubility parameters by inverse gas chromatography has a long tradition, there are new theoretical and practical developments. [56, 68] For future applications, it is interesting to evaluate different calculation methods for inverse gas chromatography. The use of the Flory-Huggins interaction parameters is quite abundant but the theory was developed initially for polymers so that small molecules may be better described by, for example, the Bragg-Williams interaction parameters. [53] Other experimental methods to determine solubility parameter Besides the typical methods described in the section above, a number of other analytical techniques used to determine the solubility parameter have been reported. These include swelling, [69] [70] [71] [72] [73] [74] turbidity, [40, [74] [75] [76] [77] ultraviolet spectroscopy, and differential scanning calorimetry (DSC) as well as differential scanning microcalorimetry (lDSC). [78] Gee described [79] the swelling of rubber in various liquids to derive its solubility parameter, an approach which has also been applied in more recent studies. For example, Eroǧlu et al. [73] and C ßavus ß et al. [69] measured the weight of a polymer before and after addition of different solvent systems with known solubility parameters by gravimetry and then defined the solubility at the point where optimal swelling was observed. Furthermore, C ßavus ß et al. [69] also investigated the swelling of PVC and found good correlations to the theoretical calculation of the solubility parameter based upon the van Krevelen-Hoftyzer and Hoy methods. [69] The simplicity of the method is highly attractive but the swelling must be of course detectable.
For turbidimetric titration, a polymer (or another relevant excipient) is dissolved in an appropriate solvent. A second solvent that is miscible with the first solvent but acts as anti-solvent for the polymer is then added until precipitation occurs. Shu and coworkers [75, 76] developed a method whereby the solubility parameter could be determined from these data. As described above Klar and Urbanetz [40] showed good correlation between the solubility parameter for HPMCAS determined by inverse gas chromatography and turbidity titration. In addition, Schenderlein et al. [74] reported the turbidity titration to be more precise relative to the swelling approach when investigating different proportions of lactide to glycolide for poly(d,l-lactide-co-glycolide) (PLGA). Carvalho et al. [78] used several methods to determine the solubility parameter for naphthalene, phenanthrene and pyrene and reported UV-vis as the most suited method for a wider molar mass range. For compounds with a low molar mass determination of the vapour enthalpy by DSC was argued to be better based on the similar results and a lower quantity of compound consumption, whereas the lDSC method still required some optimisation. Miecszkowski [46] used refractive index in several solvents to determine the partial solubility parameter for polystyrene and compared these experimental results together with calculations according to the Van Krevelen approach. Ravindra et al. [38] derived the solubility parameter of chitosan from intrinsic viscosity, surface tension and the dielectric constant for data comparison including different group contribution calculations. The average of the calculation methods yielded 43.1 MPa 1/2 for chitosan, while the experimental data provided 41.5, 39.8 and 37.0 MPa 1/2 when determined by viscosity, surface tension and dielectric constant, respectively. This demonstrates the variation that might be seen across methods. All of the mentioned approaches have their specific assumptions and limitations both with experimental design and data evaluation.
Group contribution methods to calculate partial solubility parameters
The partial solubility parameters describe the ability of a molecule to interact with another molecule via intermolecular forces. Given that molecules contain several structural fragments/groups that can contribute to such molecular forces and volume, group contribution methods are meaningful to estimate solubility parameters based only on the chemical structure. The most frequently applied methods are the approaches described by Hoy, [80] Fedors, [81] and Van Krevelen and Hoftyzer, [82] however newer approaches have also been reported, e.g. by Stefanis and Panayiotou. [5, 83] An example of solubility parameter calculation is given for lacidipine according to Hoftyzer/Van Krevelen (Table 3) . Group contribution calculations are attractive as they require pure in silico approach, which demands less computation time compared to, for example, molecular dynamics simulations.
A solubility parameter from calculations or modelling is typically a bulk property of a liquid or of a supercooled melt. For that reason, it is essential to know whether a compound or polymer is completely amorphous or contains crystalline parts, which may affect precision of the calculation. Computational concepts assume values for atomic or group contributions to the total cohesive energy. Most of the computational methods are related to the molar volume V m of a substance, thus V m has to be either known or calculated. Therefore, some researchers published values of group contributions to V m , as in some cases, reliable values of solubility parameters can be calculated best, when using two complementary methods. Whereas, other concepts, e.g. the concept by Hoy, are suited to be combined V m ascertained by experimental techniques. [80] Especially for high molecular materials as polymers, experimental determined V m can provide more precise values for solubility parameters, although an experimental determined V m is not recommended in all cases. For example, the method proposed by Fedors can only yield concise results when using the correlated calculation concept for V m , as V m of Fedors' method is often different to other calculations or experimentally determined V m . Based on such differences it would be a pragmatic approach to use different in silico methods to work with the mean of these predictions. [32, 38] Based on these group contribution components the partial solubility parameters can be calculated;
From which the total solubility parameter can be calculated:
The ease of the calculations has seen group contribution approaches being widely adopted, e.g. Shah and Agrawal [84] used the Van Krevelen and Hoftyzer method to estimate [85] [26, 27, 32, 35, 85] which are often compared to experimentally obtained data. Besides the classical group contribution methods it is in principle also possible to employ, for example, the COSMO-RS [86] approach, molecular dynamics simulations, [87] or quantitative structure-property relationships. Future research may compare such a modern approach to classical group contribution methods for pharmaceutical dataset.
Applications of solubility parameters in pharmaceutics
Organic solvent selection Knowledge of solubility in pure solvents and solvent mixtures is crucial for designing the crystallisation process of drug substances. The first step in finding the optimal crystallisation conditions is usually a solvent screening. To minimise time and resource investment, it would be desirable to conduct in silico screenings using solubility parameters or other modelling approaches to reach an educated first guess. [88] For this purpose, the use of solubility parameters is simpler than more advanced and complex theoretical models such as COSMO-RS (conductor-like screening model for real solvents), which is computation intensive, and PC-SAFT (perturbed-chain statistical associating fluid theory), which requires extensive parameter determination. [88, 89] Thus, in silico solubility parameter determination is not the only way to rank solvents for further experiments, however it is significantly more straightforward, especially when considering group contribution methods.
Furthermore, solvent selection can be essential when considering these processes. For example, Rogers and Marangoni [90] reported that changes in solvent chemistry affected nucleation and crystal growth events and therefore defined the physical properties of obtained crystals. In addition, solvent selection can change, solventÀgelator compatibility, affecting the degree of undercooling, chemical potential, kinetics of gelation and crystal morphology. These parameters are all interrelated and can be correlated to partial solubility parameters. Liu et al., [59] studied crystallisation behaviour of two anhydrous as well as the monohydrate form of piroxicam. Interestingly, additives with a similar hydrogen bonding pattern to piroxicam facilitated crystallisation of anhydrous form I. It was argued that such additives would affect the formation of the different molecular clusters in the supersaturated solution. As a consequence, these additives had a higher ability to influence the nucleation of the different polymorphs. These data suggested that the HSP could indeed be used for preliminary screening of additives for the solid form control of piroxicam during the crystallisation processes. [59] Zhu et al. [91] used the partial solubility parameters to select the optimum solvent system for aerogels, which are open-porous predominantly mesoporous solids with a wide range of applications, including oil-spill clean-up and CO 2 capture. A HSP based search method was used to target a specific gel system and because the solvent in this case had a functional influence, its selection was of crucial importance. [91] Solubility parameters can also be used for defining extraction processes, as described by Masurel et al. [92] for the removal of tar from flue gas, but also other publication focus on the use of solubility parameters for liquid extraction, [93] [94] [95] [96] even though the applications are not necessarily pharmaceutical. In particular, the partial solubility parameters seem to have several applications within the space of organic solvent selection for either crystallisation or extraction. These processes are especially important for the final steps of drug substance manufacture and even though a solubility parameter approach, however more can be done to harness the power of the HSP in the area of pharmaceutical solvent selection.
Cocrystal and salt screening
Solubility as well as dissolution rate can be significantly influenced by the selection of a suitable solid-state form. Generally high solubility and fast dissolution rate is realised by usage of an amorphous solid-state form. [97] However, a direct use of the amorphous form, e.g. in a capsule or tablet, bears the risk of uncontrolled conversion to the crystalline solid-state form, which has inferior solubility and dissolution behaviour. Therefore, amorphous APIs are not normally used directly but stabilised by suitable formulation techniques, [98] which will not be discussed in this section. Instead, we focus on optimisation of solubility and dissolution by choosing advantageous crystalline solid-state forms. Generally, these comprise pharmaceutical salts, polymorphs -including pseudopolymorphs such as hydrates and solvates -and cocrystals. Optimisation of aforementioned properties by polymorph selection comes with the same risks as discussed for the amorphous form. Selection of metastable polymorphs increases solubility, but bears the risk of uncontrolled conversion to the thermodynamically stable form. Therefore, a thermodynamically stable polymorph is typically chosen for clinical development, and only in rare cases or when there is limited knowledge of the APIs polymorph landscape, is the metastable form selected. Examples of cases where metastable polymorphs have been used in clinical development can be found in the literature. [99] [100] [101] Additionally, compared to the amorphous state, metastable polymorphs provide a much lower increase in solubility, which is why they are less attractive to develop. A schematic summary of the enthalpic processes involved in the dissolution process is given in Figure 3 . For this reason, optimisation of solubility, dissolution rate and consequently bioavailability can be best realised by selecting an appropriate pharmaceutical salt or cocrystal. Even though salt selection is well established in the pharmaceutical industry, cocrystals have also emerged during recent years as part of more educated solid form engineering.
A comprehensive summary of salt selection is given by Stahl [102] as well as Neau. [103] Historically, there have also been a few publications which summarise the use of pharmaceutical salts. [104] [105] [106] [107] [108] From such analysis, it is clear that hydrochlorides historically represented the most frequently used pharmaceutical salts for basic APIs and the same was true for sodium if acidic APIs were used. However, in recent decades, it has been clearly recognised that these 'one-fits-all' counterions did not always lead to the desired properties intended by the salt formation. This is in line with the observation that new drug candidates entering clinical development, in addition to newly approved drugs, exhibit significantly lower solubility (BCS class II and IV) and require more individualised solutions to optimise their physicochemical behaviour. This does not only include above-mentioned solubility and dissolution aspects, but also further parameters such as hygroscopicity, melting point, chemical and physical stability as well as crystal habit. Several examples of optimising such properties can be found in the literature. [109] [110] [111] [112] In many cases, sulfonate salts such as mesylates, tosylates, napsylates and edisilates showed far better performance with regards to increased solubility and dissolution rate [113] compared to other salt forms. Lower dissolution rate of the parent (either free base or free acid) compared to pharmaceutical salts can be easily explained by the presence of ions in the crystal lattice of a pharmaceutical salt, leading to stronger interactions between the crystal lattice and water as the dissolution medium. However, a similar explanation as to why, for example, sulfonate salts generally show excellent dissolution rate so far is not available. This phenomenon remains unexplained at least by simple chemical reasoning.
However, there are other more systematic approaches to improve solubility by usage of pharmaceutical salts, which are based on mechanistic understanding: as solubility depends on crystal lattice energy, and high lattice energy will generally result in low solubility, reducing the lattice energy represents a means to improve solubility. For pharmaceutical salts, Coulomb interactions contribute with a major part to the lattice energy. Use of large, 'noncoordinating' counterions with low charges (one positive charge or one negative charge) are useful in designing such pharmaceutical salts with improved solubility. [114] In the extreme case, such pharmaceutical salts do not even represent solid APIs anymore, but become liquids. [115] [116] [117] [118] As stability can be more challenging for such ionic liquids compared to solids due to increased mobility, this certainly has to be assessed critically. Moreover, toxicological assessment and regulatory acceptance represent the major hurdles for the use of such noncoordinating ions in humans, as none of these salt formers are currently used in human beings or 'generally regarded as safe' (GRAS) by the FDA. [119] Therefore, this promising conceptual work on noncoordinating ions has not yet led to approved drugs on the market nor in clinical development.
From a more practical standpoint, several aspects must be considered for selection of pharmaceutical salts or cocrystals. The process steps include salt-or coformer screening and physicochemical characterisation with a typical focus on solubility and dissolution rate but also regarding chemical and physical stability while considering toxicological aspects of the selected salts or coformers. This screening stage represents the starting points for the selection of a salt or cocrystal, respectively. Earlier, such screening was carried out as a typical synthesis process in lower gram-scale. Today salt or coformer screening is conducted on the lower mg-scale which saves API and allows conductance of such screens earlier during the research process. For this purpose, different screening approaches exist in the pharmaceutical industry. A salt or cocrystal screening might be carried out in an automated way using robotic systems that employ different solvents and solvent mixtures according to a fixed protocol. Alternatively, salt or cocrystal screens can be based on a rationale, nonautomated process where small-scale crystallisation trials are performed and crystallisation is closely observed. This allows information to be obtained sequentially from one experiment to another. Even though for a single trial, larger amounts of API are required compared to the automated approach a repetition of unsuccessful experiments is avoided. A useful comparison of different screening approaches can be found in the literature for salt selection. [120] Following initial screening of possible salt and cocrystal formation, characterisation of solid-state properties, including melting point, hygroscopicity and stability is important; as well as analysis of solubility, dissolution and supersaturation. The aforementioned steps to salt and cocrystal formation offer different opportunities to use solubility parameters. One application is certainly the selection of organic solvents or antisolvents for solid form screening, which is in line with the previous section. Other applications of partial solubility parameters are selection of ionic liquids even though they are still currently quite toxic or not sufficiently characterised leading to regulatory hurdles in pharmaceutical development. More important therefore are applications to the field of cocrystals where it has been attempted to predict formation based on HSP. [121] A recent study conducted cocrystal search of itraconazole during which the HSP was used to rank different amino acids as potentially suitable coformers. [122] In spite of such reports, there are also typical limitations of solubility parameters because they cannot account for specific aspects of the crystal lattice. There are currently methods in structural informatics that can use the Cambridge Structural Database to assist in silico screening of the energy landscape of possible crystals. These approaches together with other computational methods used in pharmaceutical solid-state chemistry have been recently reviewed in an excellent book. [123] Therefore, partial solubility parameters can be applied successfully in the field of salt and cocrystal screening, however in cases where details of a crystal lattice energy landscape should be considered, alternative methods of solid-state modelling are recommended.
Solubility parameter concept in lipid-based formulations
Lipid-based formulations have been an important part of the toolbox to formulate low water-soluble compounds for over 50 years. Additionally, an increased prevalence of such poorly soluble drug candidates in the last two decades has also intensified the interest in lipid-based drug delivery systems (LBDDS). The biopharmaceutical advantages of LBDDS include the potential to enhance bioavailability, decrease pharmacokinetic variability as well as food effects, promote lymphatic absorption and support controlled drug release. [124] A key element of LBDDS is that the drug substance is dissolved within the lipid excipients before administration, hereby presenting the drug in a presolubilised state in the gastrointestinal tract. The level of solubility in the LBDDS is, hence, important to achieve the above-mentioned biopharmaceutical advantages. Therefore, options to predict and rank drug solubility in lipid excipient mixtures are of high interest to guide LBDDS formulation development. Generally, the solubility in lipid excipients is determined experimentally; however, these experiments are costly, time-consuming, resource-intensive and the experimental protocols vary substantially between different research groups. [125] Also, LBDDS are often mixtures of different excipients, e.g. lipids, surfactant and cosolvents, so the number of typical solubility studies required can be very extensive. [125, 126] Recently, the utility of empirical models to predict drug solubility in lipids has been explored, using multivariate data analysis with several molecular descriptors. [125] [126] [127] A disadvantage of any such multivariate approach is that the size and quality of the calibration dataset highly influences the accuracy of the prediction. Thus, an alternative to complex computational models, is the HSP approach that has been proposed to guide lipid-excipient selection. Dumanli et al. [128] used the HSP to rank compound solubility and miscibility in/with lipids. The required solubility parameters can be obtained either from experiments or from calculations as previously outlined in Section 2. For lipid-based excipients, vapour pressure and boiling point determinations, miscibility of reference liquids (with known cohesive energy), inverse gas chromatography and calculations using group contribution methods are of particular interest to determine HSP. [129] Solubility parameters have been commonly employed for this purpose, especially for characterisation and release of raw materials for cosmetics [130] [131] [132] and in the oil and textile industry. [133] However, there are not many applications of solubility parameters for lipid-based systems in the pharmaceutical field. Most studies determine the solubility parameter using theoretical group contribution approaches and often only consider simple mixtures, i.e. compound A in oil B. [84, 134] De La Peña-Gil and coworkers [135] investigated methods to predict and calculate HSP of complex lipidic mixtures (i.e. vegetable oils) using the HSPiP software. [67] Two approaches were used to determine HSPs. In one approach it was assumed that each functional group (fatty acids, fatty acids + glycerol and fatty acid methyl esters) present in triglycerides, had an additive contribution to the dispersion, dipole-dipole and hydrogen bonding interactions. Therefore, the composition of triglycerides was divided into different functional groups and each component of the total HSP (d t ) was calculated (i. e. d d , d p and d h ) . The second approach assumed that vegetable oils are mixtures of simple triacylglycerols in the same mass fractions as the fatty acids. [135] Two studies by Shah and Agrawal [84, 136] investigated the utility of HSP as a predictor for optimal carrier and solvent system selection: [136] firstly to describe the solubility behaviour of a drug (ciprofloxacin HCl) and lipid excipients and secondly, for the design of solid lipid nanoparticles (SLNs). [84] Both studies used the Van Krevelen/Hoftyzer group contribution approach to calculate the HSP for different solvents, polymers and lipids using the Molecular Modeling Pro software. Calculation of the solubility parameter was based on at single repeating polymeric unit for the polymers whilst, for lipids consisting of mixture of glycerides the calculation was carried out based on an average predominant ratio. [136] With the Van Krevelen approach, the molar attraction constant (F) was calculated and all the extended HSPs determined. The calculated values of the total HSP were matched between different lipids, organic solvents and drug compounds and when similar values were observed then the systems were considered miscible. Shah and Agrawal [84] validated the mathematical model used by experimental testing of drug solubility in the selected excipients and solvents. Both studies [84, 136] succeeded in qualitatively predicting the solubility of ciprofloxacin HCl in different lipids and subsequently the solubility of lipids in various organic solvents using the HSP determination/calculation. This approach resulted in identifying the most promising lipid candidates for maximum drug loading in SLN formulation consisting of glyceryl monocaprylate and glycerol monostearate 40-55. These studies demonstrate the possibility of using the HSP for optimal selection of excipients in designing SLNs and qualitative prediction of excipient-drug compatibility.
Another application of the HSP was suggested by Li et al. [137] to estimate the compatibility between materials to facilitate the design of polymer-lipid hybrid nanoparticles (PLN). Specifically, the enthalpies of mixing for a drugpolymer complex (i.e. verapamil in dextran-sulfatesodium) and 15 different lipids including triglycerides, fatty acids, glycerol esters and mixtures of glycerol esters were predicted by accounting for the volume fractions of components in the mixture. The study also used the Van Krevelen/Hoftyzer group contribution approach to calculate HSP and showed the suitability of the HSP theory in the screening of lipid carriers for PLN design of verapamil. [137] While useful to determine how a lipid or lipid mixtures may behave as solvent(s) and the possibility to predict how some compounds solubilise in lipids, the HSP concept has also some limitations. Firstly, the concept only considers the energies derived from direct contact of components and does not account for the entropy effects and the free volume of, for example, amorphous solids. [84] The free volume is defined as an empty space in a solid or liquid that is not occupied by the molecules. Generally, amorphous solids are inefficiently packed and present a considerable amount of free volume compared to ordered materials. Additionally, it was mentioned before as a disadvantage that a given crystalline solid-state form is not accounted for. By contrast, experimental HSP determinations are generally conducted with the most stable polymorph. Studies have suggested that HSP calculations based on group contribution methods provide accurate predictions if materials with similar structures are compared, as the calculation does not account for the dependencies on conformation, concentration and specific intermolecular interactions that might occur in binary mixtures. [134] Finally, another limitation of the theoretical model is that it disregards specific self-association of molecules, which is also the case with further thermodynamic approaches other than SAFT (statistical associating fluids theory) calculations.
The HSP approach within LBDDS has only been investigated to a limited extend, potentially due to the variability and complexity of the lipid excipient composition and the multitude of drug-excipient interactions. However, there are further pharmaceutical applications that are to some extent linked to lipids in general such as intestinal drug absorption, [138] skin penetration of topically applied drugs, [139] and prediction of drug-nail interactions. [140] The available studies suggest that partial solubility parameters have the potential to be a useful tool in early development of LBDDS.
Solid dispersions

Amorphous solid dispersions
Modification of the solid drug form to increase solubility and dissolution rate has been mentioned before (Cocrystal and salt screening section). In this endeavour, the high energy that the amorphous state can provide is especially interesting. [2, [141] [142] [143] However, the amorphous state is thermodynamically unstable and tends to revert to a crystalline polymorph. The amorphous drug state can be stabilised by solid dispersion, [144, 145] complexation with large (e.g. cyclodextrins) [146] or small molecules, [147] and spatial confinement (e.g. absorption on silica). [148, 149] Solid dispersions involving the immobilisation of amorphous API in polymer have been studied extensively in the literature [145, [150] [151] [152] and are one of the most widely employed approaches to formulate an amorphous drug form. Amorphous solid dispersions (ASD) is an umbrella term for different types, which can be glass solution, glass suspension and solid solutions of drug in the carrier. [145, 153] Drug-polymer miscibility is a key parameter to consider when formulating solid dispersions [154, 155] and to obtain a single phase system, both the API and the carrier have to be miscible. Such miscibility can be calculated using advanced thermodynamic models, such as the previously mentioned PC-SAFT and COSMO-RS theories or the simpler FloryHuggins model may be applied. [156] The advantages of suitable prediction accuracy of advanced thermodynamic approaches have to be balanced against drawbacks like either extensive computation time or the need for parameters that have to be based on extensive experimentation. This makes the simpler solubility parameter approach very attractive and either the total Hildebrand solubility parameter can be considered or partial solubility parameters. Thus, HSP has been extensively used to identify drug-excipient miscibility with a general rule of thumb that molecules with similar d values are assumed to be miscible. [32, 121, 155, 157] This method considers the dispersion and polar interactions of a system as well as the hydrogen bond contributions of the test molecules. We emphasise again that HSP hereby addresses the main limitation of the conventional Hildebrand solubility parameter, which does not discriminate the different partial contributions to cohesive energy density. [1] However, ASD formulation miscibility has been investigated with both the Hildebrand [158] as well as the Hansen [85, [159] [160] [161] approach. It was proposed by Greenhalgh and coworkers [155] that systems with a difference in solubility parameters from 1.6 to 7.0 MPa 0.5 present no miscibility problems. However, substances with a difference of 10.8 to 18.0 MPa 0.5 were considered immiscible. Further practical measurements showed that systems with a difference of 1.6 to 7.5 MPa 0.5 could be considered miscible in the molten stage. Systems with a difference of 7.4 to 15 MPa 0.5 were slightly immiscible in the liquid state. Total immiscibility was observed in systems with differences greater than 15 MPa 0.5 . [155] With the Hansen approach similar observations were made when testing the miscibility of 2 drugs in 11 excipients. [85] Systems that were predicted to be miscible using the Greenhalgh values formed glass solution via hot melt extrusion while those combinations that were predicted to be immiscible formed solid dispersions in which the amorphous drugs was dispersed in crystalline carriers. On the other hand, when the Hildebrand approach was utilised in combination with logP, pK a and T g considerations, amorphous miscibility between additives and polymers failed to be predicted for systems in which acid-base interactions took place. [158] Systems which were predicted to be immiscible, but showed acid-base interactions, still resulted in ASD formulations. Contrastingly, this approach accurately predicted miscibility and ASD formation for systems produced via a solvent evaporation method without acid-base interactions. This underlines again that the Hildebrand concept with a single value for total solubility parameter cannot adequately account for specific or hydrogen bonding interactions.
As mentioned previously, the HSP concept offers a 3-D solubility parameter concept that can be visualised in the Hansen space (Figure 1) . A way to project a 3-D solubility parameter in a two-dimensional plane was proposed by Bagley et al. [162] It was argued that the thermodynamic contribution to the solubility parameter of the polar and dispersion interactions are often similar, and therefore, a combined solubility parameter (d v 2 ) can be derived from Equation 8 to yield the following Equation [162] :
The plot of d v vs d h , simplifies the 3-D Hansen space into the 2-D plane, which is referred to as a Bagley plot. Analogues to the previously discussed Hansen space, it is assumed that molecules in vicinity of each other are more likely to be miscible. [32, 154] The Bagley plot has been utilised to evaluate and predict miscibility between molecules using the R a(v) parameter, which gives an idea of the 'area of miscibility' around a molecule, and should be ≤5.6 MPa 1/2 for miscibility. This parameter is analogous to the R a in Equation 21 but uses the simplification of Equation 39 to a drug-polymer system:
Bagley plots are highly versatile and have been used to investigate the miscibility of polymers in solvents, [82] drugs in excipients [32, 154, 157] and polymers in polymers. [163] It is important to consider the selected method when calculating solubility parameters, as different methods can give rise to different Bagley plots, which was highlighted by Meaurio and colleagues. [163] These theoretical considerations were applied to ASD formations by different authors. [154, 157] One study tested 84 drug molecules for their miscibility in PEG and demonstrated a good correlation between the group of drugs forming ASDs with PEG with the plot region around PEG derived from theoretical solubility parameter calculation. [154] Alhalaweh et al. [157] compared experimentally derived miscibility data of indomethacin and excipients with predicted miscibility data. The Bagley plots of these data sets were almost identical and the predicted data showed a good correlation to the ASD formation.
Another prerequisite for the formation and stability of successful ASDs is that the change in the free energy of the system upon mixing should be negative. Because ideal mixing increases the entropy of the system, the entropy contribution should facilitate mixing. Consequently, it is the enthalpy contribution that may prevent free mixing energy DG m to be negative. In drug-polymer systems the FloryHuggins equation has been adapted to align with the lattice-based Equation (40) used for the dissolution of polymers in solvents [164] [165] [166] [167] as previously described in Equation 5 .
where subscript d and p describe drug and polymer respectively, while DH m can, also, be given by the van Laar expression according to Equation 42 :
From Equation 42 it can be seen that the value of the drug-polymer interaction parameter, v dp , could be a surrogate for the enthalpy of the system, for given conditions. By combining Equations (40) and (41) , the drug-polymer interaction parameter can be given by Equation 42 (neglecting b) which is in line with the previously discussed Equation 6 :
where V dp is volume of mixture, φ d and φ p are volume fractions of drug and polymer, and d d and d p are solubility parameters of drug and polymer. Similar to the total (or Hildebrand) solubility parameter, the HSP has also been linked to the drug-polymer interaction parameter (v dp ) by consideration of partial contributions to cohesive energy density. [82] The drug-polymer interaction parameter has been used widely for the investigation of binary mixtures especially, miscibility based on a negative DG m. . Although this parameter can be determined by melting point depression, [165, [167] [168] [169] there are also some studies that use the 3-D solubility parameter approach [154, 167, 169] to investigate drug-excipient miscibility in a more quantitative way. Such construction of phase diagrams show the differentiation of single and two phase system at equilibrium (binodal line) and kinetic decomposition of metastable mixtures (spinodal line) can be estimated. [170, 171] It is attractive to construct entire phase diagrams but this objective is more ambitious than use of the solubility parameters to simply rank excipient selection based on rules of thumb, such as based on the proximity of drug and excipient representations in the Hansen space or Bagley plot. A key strength of the solubility parameter is that such approaches are in general rather simple. A more ambitious quantitative calculation of entire phase diagrams can suffer from the simplifications of the thermodynamic approach as well as from lacking prediction of solubility parameter estimates. Phase diagrams constructed via solubility parameters might therefore be better considered as a first approximation only.
Mesoporous silica
Recent developments suggests mesoporous silica as a new and promising material to formulate poorly water-soluble drugs with the intent to increase dissolution rate and solubility. [149, [172] [173] [174] [175] [176] Loaded mesoporous silica is prepared via adsorption of API from a concentrated organic solution followed by evaporating the solvent. This adsorption into the porous network stabilises the API in the amorphous state, due to steric effects. Upon administration, the amorphous API is then released and the dissolution is increased. [173] Utilisation of the solubility parameter in the development of amorphous mesoporous silica is still largely unemployed without commercial formulations that are globally on the market. This represents a key gap in the literature, as solubility parameters can guide the selection of suitable solvent to maximise the penetration efficiency of API into mesoporous silica, which was demonstrated by Hideo Hata and coworkers. [177] They showed that, of six different solvents used to incorporate taxol onto mesoporous silica, only two resulted in effective loading of the API. They concluded that solubility parameter was a key factor in this observation; where solvents that interacted strongly with taxol resulted in the most effective loading, whereas those with weak interaction showed poor loading efficiency. Such interaction can be determined using solubility parameter approach. [177] However, the range of solvents suitable for use with formulation development is limited. Those solvents that show the strongest solubilisation power are often seen as 'no-go' solvents based on ICH guidelines. [178] Therefore, most instances of mesoporous silica use in the literature are carried out with either ethanol, acetone or dichloromethane, with even the latter being less utilised due to toxicity considerations. [149] The ICH list certainly limits solvent selection but not to the extent as it is currently reflected in the literature on mesoporous silica so there is a potential to access a wider range of solvents by employing a rank-order-based protocol based on in silico solubility parameter calculation.
Amorphous solid dispersions systems have proved to be a useful formulation tools in battling the solubility issues of pharmaceutical molecules. However, because of their limitations in stability, miscibility of the system is of crucial importance for a successful formulation. This makes the identification of tools to evaluate miscibility in the development phase, not only useful, but imperative. Herein the application of solubility parameter concepts to assess miscibility has been reviewed and discussed in the previous section. It should be emphasised again that a consideration of partial solubility parameters is preferred to a simple comparison of total (i.e. Hildebrand) solubility parameters. Moreover, the need of a complete database for partial solubility parameter either for drug and polymer was highlighted when using HSP. A limited number of data is not only available with respect to experimentally determined values but also for group contributions as used for in silico prediction of solubility parameters. The latter limitation can be especially troublesome in case of HSP estimation for more complex drug molecules. Application of the modified solubility parameter approach was applied by Piccinni [179] and even though the usefulness for early excipient ranking was recognised, it was also emphasised that physical screening tests should not be replaced by the in silico method until more robust prediction methods are available. This supports what was discussed in the previous sections that solubility parameters can be calculated in silico to rank excipients for a subsequent experimental screening. Such a screening phase can therefore be designed in a more focused and cost-effective way rather that be entirely replaced.
Application of solubility parameters in the formulation of nano-and microparticulate systems
One of the most used methods for dissolution improvement of poorly water-soluble drugs is particle size reduction. The decrease in size increases the surface to volume ratio, which accelerates dissolution kinetics. Especially interesting here are sizes well below 1 lm, which have the highest potential increase the kinetic drug solubility [180, 181] in addition to the dissolution rate enhancement. Thus, by bringing particle size to the nanoscale, solvation pressure increases and facilitates the disruption of the intrasolute bonds thus promoting solubilisation. [182] Micronisation and nanosizing methods can be grouped into two categories: the top-down methods that entails size reduction of bigger particles by the use of shear forces and the bottom-up methods that involve the isolation of drug particles after recrystallisation from a highly supersaturated drug solution. [181] Although traditional micronisation techniques, such as dry-milling, are still being used, bottom-up approaches are becoming increasingly sophisticated, gaining merit as techniques that can circumvent typical process limitations. [183] These limitations may involve unwanted amorphisation, disruption of the crystal lattice and unpredictable particle size distributions. [184] However, bottomup approaches also face their individual limitations. Due to the fact that they rely on the controlled precipitation of particles from supersaturated solutions, miscibility and solubility considerations should be taken into account for the optimal choice of formulation combinations.
Moreover, technical developments in both top-down (e.g. 'pearl' milling and high-pressure homogenisation) and bottom-up techniques (e.g. new-generation spray dryers, supercritical fluid technology and freeze drying) have broadened the availability of nanosizing approaches. As nanoparticles exhibit high surface cohesive energies, they are especially prone to aggregation, [185, 186] making their stabilisation indispensable. The use of various stabilisers, often surfactants and/or polymers, has been reported. It is proposed that they work by sterically or ionically stabilising the surface of nanoparticles, to limit aggregation. [187] The choice of appropriate stabilisers seems to greatly depend on the physical characteristics of the surface of drug molecules. [188] Consequently, the need for reliable tools to estimate possible candidates for nanoparticle formulations is evident.
Several attempts for nano-and micronised formulations have been reported in literature using a variety of materials including proteins, lipids and polymers. [189] We considered here not only the classical top-down and bottom-up approaches but more broadly reviewed also micro-and nanoparticle formation. Calculated solubility parameters are used eventually here as an early evaluation of miscibility of solvent-solute combinations as well as miscibility between molecules. However, evidence of using solubility parameters later during formulation development is very limited. To the best of our knowledge, only few relevant literature references exist, i.e. where a solubility parameter approach has been used for choosing the appropriate lipids in drug-polymerlipid nanoparticles, [137] for choosing the drug-polymer combinations for the construction of polymeric micelles and for predicting drug loading. [190, 191] Furthermore, Mahmud et al. [191] and Dwan'Isa et al. [190] used the HSP to calculate the Flory-Huggins interaction parameter of drug-polymer combinations (v dp ) and considered it as a measure of miscibility. [192] Dwan'Isa et al. tested 19 drugs for their interactions with a diblock copolymer (MePEG-b-(PCL-co-TMC)), while Mahmud et al. studied the interactions of one anticancer drug (curcubitacin I) against a variety of core-forming polymers. In both studies, the calculation of the v dp parameter was able to reveal the optimal drug-polymer combinations, as well as to predict the drug loading capacity of the polymer micelle formulations. Even though the calculation of the interaction parameter provided a reasonably accurate method for the qualitative prediction of drug solubilisation in the polymeric micelles, a definite rank order of combination miscibility among the variations tested could not be achieved, which may be attributed to the limitations of the Flory-Huggins theory as well as lacking accuracy of estimating the interaction parameter. Simplifications included the disregard of polymer molecular weight and polymer solvent interactions. [192] Nevertheless, the calculations of the HSP and the Flory-Huggins interaction parameter have been proven to be adequate tools for the primary selection of potentially miscible nano-and microparticulate systems, which helps in reducing the number of early screening experiments.
Conclusions
Solubility parameters have proven to be useful in diverse scientific fields, and this review has outlined the different applications concerning oral delivery of poorly water-soluble compounds. These compounds typically require bioenabling formulation for successful development and solubility parameters can help, for example with ranking of solvents and excipients to achieve a more focused formulation development. Herein, predictions based on chemical structure are particularly interesting as only limited compound is available in early development. Despite the usefulness of applying solubility parameters in pharmaceutics, there are also some gaps. In particular, drugs in a solid crystalline state or also rather complex molecules in general may result in erratic predictions of solubility parameters. However, it is promising that new theoretical developments have been reported that present conceptual improvements. Moreover, experimental methods such as high-throughput solubility testing or greater availability of inverse gas chromatography will help in generating more data. Important is to obtain more comparative data of experimental and computational methods to better learn about variability of results. This can in turn help to further improve in silico predictions of solubility parameters, and a just accepted article has been following this research direction. [193] Therefore, it can be expected that solubility parameters will also in the future rank among the mostly used thermodynamic approaches in pharmaceutics.
Declarations
Conflict of interest
The Authors declare that they have no conflict of interests to disclose. 
